Immediate Impact
1 from Science/Nature 62 standout
Citing Papers
The molecular mechanism and therapeutic landscape of copper and cuproptosis in cancer
2025 Standout
Targeting ROS in cancer: rationale and strategies
2024 Standout
Works of Albert J. Bonebrake being referenced
A phase II evaluation of elesclomol sodium and weekly paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube or primary peritoneal cancer: An NRG oncology/gynecologic oncology group study
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Albert J. Bonebrake | 194 | 233 | 96 | 223 | 22 | 507 | |
| Maria-Pilar Barretina-Ginesta | 217 | 225 | 64 | 181 | 31 | 470 | |
| P. Iyengar | 128 | 152 | 109 | 147 | 22 | 507 | |
| Cyril Abdeddaim | 163 | 281 | 90 | 173 | 30 | 489 | |
| Yukihisa Minagawa | 208 | 196 | 49 | 170 | 35 | 559 | |
| G. Salerno | 119 | 196 | 52 | 140 | 20 | 540 | |
| Edmonson Jh | 197 | 246 | 157 | 103 | 27 | 560 | |
| Susan B. Ingersoll | 112 | 143 | 54 | 136 | 21 | 510 | |
| Daniel Donato | 170 | 137 | 66 | 268 | 29 | 524 | |
| Whitney A. Spannuth Graybill | 215 | 200 | 55 | 87 | 35 | 520 | |
| Bernd‐Uwe Sevin | 200 | 149 | 55 | 269 | 28 | 567 |
All Works
Loading papers...